Login to View
StrategyR is a trade mark of Global Industry Analysts, Inc. USA
A trade mark of Global Industry Analysts, Inc.


Myeloproliferative Disorders Drugs

A Global Strategic Business Report

MCP22342


RESEARCH TRANSCRIPTS
Merck and Co & Harvard Medical School: collaboration over osteoperosis
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Fintan Walton talks to Alan Ezekowitz & Laurie Glimcher of Merck and Co & Harvard Medical School about their collaboration in the area of osteoperosis.

TRANSCRIPT:

#ChatsWithChaudhrey w Kashyap Bhatt, Manager Pharmacovigilance, Takeda, Pharmaceutical Microbiology
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

I caught up with Kash yesterday who is speaking this week at SMis Pharmaceutical Microbiology East Conference on "Inspections the do's and don'ts" We discussed... What key developments had he witnessed in Pharmaceutical Microbiology over the past year? What did he see as the greatest challenge for him to overcome personally in pharmaceutical microbiology? What his thoughts were the developing regulatory environment for pharmaceutical microbiology and how is this impacted his role? What his presentation is covered and why should be people attend it? And finally, how would he like to see the pharmaceutical microbiology market develop in the future and where he thought the biggest growth area going forward. If you are attending Pharmaceutical Microbiology East Coast this week which runs from Wednesday 28th to 29th April make sure to checkout his presentation - it's the last one on Thursday, - as its well worth listening too. You can still register for the event here. https://tinyurl.com/47x77t5c Feel free to leave Kash any questions and comments below. See you there.

TRANSCRIPT:

11th HPAPI Summit | Takeda Pharmaceutical Interview
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

In preparation for the 11th Annual HPAPI Summit, program director Jennifer Small speaks to Takeda Pharmaceuticals' Brian Schmidt, Global Lead, Occupational Hygiene and Andrea Guytingco, EHS Business Partner. To learn more about what Takeda will be covering at the summit click here: https://hpapi-summit.com/program/full-event-guide/

TRANSCRIPT:

Акции Takeda Pharmaceutical (TAK), препараты Esperion и перспективы крипты
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Исправляю небольшую ошибку из прошлого ролика о препаратах Esperion – NEXLIZET (бемпедоевая кислота и эзетимиб) и NEXLETOL (бемпедоевая кислота). Они, как и статины, понижают холестерин, однако действуют на фермент цитратлиаза АТФ в отличие от статинов, которые действуют на 3-гидрокси-3-метилглютарил-кофермент А редуктазу. Мы не медики, поэтому в таких деталях можем ошибаться ) Также рассматриваю компанию Takeda Pharmaceutical (TAK), говорю, почему её акции являются хорошей инвестицией и почему я сам сейчас их не покупаю. В конце рассказываю о криптовалюте и связанных с ней компаниях. 00:00 Вступление 00:26 Исправляем ошибку о препаратах Esperion 01:33 Анализ компании Takeda Pharmaceutical (TAK) 04:10 Какие компании солнечной энергетики выросли 04:59 Что я думаю о крипте и компаниях Coinbase Global (COIN) и MicroStrategy (MSTR) 07:09 Почему бывают ошибки #Takeda #акции #TAK

TRANSCRIPT:

Takeda Pharmaceutical Taiwan Limited - HR Asia Awards 2020 Taiwan Winner
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Congratulations to Takeda Pharmaceutical Taiwan Limited as the Winner of Taiwan's HR Asia Best Companies to Work for in Asia 2020. 恭喜HR Asia台灣區域最佳企業雇主獎2020的得獎者 - 台灣武田藥品工業股份有限公司! ---------------- Email: marketing@businessmedia.asia Official Website: http://hrasiamedia.com | http://awards.hrasiamedia.com Official Facebook: https://facebook.com/hrasia | http://facebook.com/hrasiaawards Instagram: hrasiamagazine | hrasiaawards

TRANSCRIPT:

Special Thank You Message to Takeda Pharmaceutical
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Cambridge Mayor Sumbul Siddiqui and City Manager Louis DePasquale today expressed profound gratitude on behalf of the City to Takeda Pharmaceutical for its $2 million donation to the Mayor’s Disaster Relief Fund. www.cambridgema.gov/covid19

TRANSCRIPT:

Takeda Pharmaceutical Company Limited $TAK Q3 2023 Earnings Call
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Takeda Pharmaceutical Company Limited $TAK Q3 2023 Earnings Call Listen to the latest conference call between the company and financial analysts or investors as they discuss the company's financial performance. During the call, company executives, including the CEO and CFO, provide an overview of the financial results, discuss the company's performance and strategy, and answer questions from analysts and investors. Earnings calls are typically conducted via teleconference and are open to the public, although they may also be webcast or recorded and made available for later playback. Earnings calls provide an opportunity for investors and analysts to get more information about the company's financial performance and to ask questions about the company's business. Overall, listening to an earnings call can help investors and analysts get a better understanding of a company's financial performance and future prospects, which can inform their investment decisions. Please visit the company's investor relations website for more information.

TRANSCRIPT:

Обзор рынка иностранных акций, в фокусе: PayPal, Tesla, Exxon Mobil, Takeda Pharmaceutical
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Главные события фондового рынка 22 октября. Караул устал… Уже невооруженным глазом видно, как надоела инвесторам текущая ситуация. Ожидание, ожидание, ожидание и более ничего. Максимум, что отыгрывается на рынке - это отдельные корпоративные новости. Однако в целом это мало влияет на общее положение вещей. Так и сегодня – вроде бы есть серьезный повод для оптимизма. Блестящая отчетность инновационной компании Tesla (TSLA), которая реально порадовала всех – и аналитиков и конечно уж инвесторов. Как сказал отец-основатель Tesla Илон Маск: «Прошедший квартал оказался самым лучшим в истории компании». Сразу же после выхода отчетности акции Tesla выросли более чем на 5% и держатся на этих уровнях и сегодня с утра. Однако одной Теслы явно мало для того, чтобы взбодрить весь рынок. Все мировые фондовые рынки сегодня с утра окутаны туманом пессимизма. И Азия, и Европа и даже фьючерсы на основные американские индексы – все поголовно окрашены в красный цвет. Нет, это не распродажа. Падение составляет часто всего лишь несколько десятых процентов, но красный цвет говорит сам за себя. Кроме общих печалей, связанных с затягиванием утверждения Программы стимулирования, сегодня могут прилететь еще и неблагоприятные вести со стороны выхода макроданных по безработице. В 15-30 Мск как обычно по четвергам будут опубликованы данные о количестве первичных и повторных обращений за пособием по безработице за последнюю неделю. Несмотря на то, что аналитики прогнозируют некоторое снижение – с 898 до 880 тысяч новых обращений, сама по себе эта цифра просто ужасающая и понижательного тренда не наблюдается уже более 3 месяцев. Короче, радоваться пока, к сожалению, нечему и скорее всего мы сегодня увидим достаточно плавное сползание котировок по всем направлениям. Пока, к счастью, плавное – поскольку надежда, как говорится, умирает последней. А надежды все же еще есть. Об этом и многом другом рассказывает Павел Пахомов, руководитель Аналитического центра Санкт-Петербургской биржи, на ежедневном вебинаре "Пульс Wall Street". Подписывайтесь на канал Санкт-Петербургской биржи и присоединяйтесь к ежедневным онлайн трансляциям! _________________________ Вся информация, представленная в настоящем обзоре, носит исключительно информационный характер, не является инвестиционной консультацией, рекомендацией или предложением к совершению сделок с финансовыми инструментами. ПАО «Санкт-Петербургская биржа» не несет ответственности за последствия использования размещенной информации, в том числе за любые возможные убытки от сделок с финансовыми инструментами.

TRANSCRIPT:

Die Takeda Pharmaceutical Aktie - 5% Dividende aus Japan
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Heute stellen wir euch Takeda Pharmaceutical vor. Die Pharmafirma aus Japan gehört inzwischen zu den TOP 10 Pharmafirmen der Welt und schüttet zum Zeitpunkt unserer Veröffentlichung, eine schöne Dividende in Höhe von 5% aus. Links: History of Takeda: https://www.youtube.com/watch?v=xYglnOyZrpM&t=20s Takeda auf YouTube: https://www.youtube.com/channel/UCOaSrsYBpIQSxnW7badEtDg Takeda Philosophie: https://www.youtube.com/watch?v=hiofNFRyvuk&feature=emb_logo Inhalt: 0:00 Begrüßung 2:00 Imagevideo Takeda Pharmaceutical 3:25 Disclaimer 5:55 Kurzportrait 10:28 Top 10 Pharma Unternehmen 13:54 Geschäftsbereiche von Takeda 15:48 Die Transformation 18:08 Erreichte Ziele 20:50 Ausblick 10 Jahre 23:15 R&D Focus 27:52 Die Pipeline 34:52 Marktpotential 37:00 Markenübersicht 39:22 Wachtsumspotential 42:50 Zahlen und Ausblick 44:16 Positionierung 46:22 Fair Value 47:43 Finanzkennziffern 48:10 Die Aktionäre 49:13 Unternehmensbesitz 50:15 Unsere Käufe 53:06 Ark Invest Käufe von Takeda Shares 57:30 Discord und Verabschiedung *** Aktien Noobs im Social Media *** Twitter: https://twitter.com/EneNoob Instagram: https://www.instagram.com/aktiennoobs/ Der Aktien Noobs Discord Server! https://discord.gg/6zken9fmHF ***

TRANSCRIPT:

World Pack Talk Show: Interview with Sriman Banerjee, from Takeda Pharmaceutical
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

WPO interviews Sriman Banerjee, from Takeda, about trends and innovations in the pharmaceutical packaging industry, considering the challenges imposed by Covid-19.

TRANSCRIPT:

Takeda Pharmaceutical Company
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Important People, Events, Places & other entities in last 27 years. This is based on news coverage & wikipedia views data & importance. NLP & Machine Learning used to filter out the entities.Wikipedia is used as a data retrieval platform & Google's text-2-speech is used to make audio. Whole process is automated. This is first attemp to make these kinds of short videos. If successful .. will cover more wikipedia pages.

TRANSCRIPT:

Fundamental Analysis of Takeda Pharmaceutical Company (TAK) 2022/6
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

In this video, we look at fundamentals of TAK - Takeda Pharmaceutical Company with an AI. We will use quarter of 2022 / 6 data. Our AI software prepares heat maps for your better and easy understanding. Please don't forget to subscribe. ***************************************** Fundamentals First Investing Legal Disclaimer: This YouTube channel and all content is for entertainment purposes only. I am not a financial advisor or a financial analyst. THIS IS NOT FINANCIAL ADVICE. I will not be held liable for any losses or damages resulting from the display of any written, visual, or audio content. All information shown should not be relied upon for its accuracy and is as of the date indicated. Information is presented “AS IS” and confers no rights or warranties. The views and opinions of myself and the channel may change at any time without notice. The Fundamentals Composite Score provided in some videos is provided solely for entertainment purposes and should not be used to influence, inform, or prompt any decision regarding the security or any other security. The Fundamentals Composite Score provided should not be considered complete analysis in any way and disregards many factors of securities analysis including but not limited to, technical analysis, sectoral analysis, sentiment, management, momentum, etc. Investing in the stock market on your own involves many risks, including partial or total loss of principal. It is prudent that each person asses their own complete financial situation and meet with a qualified professional financial advisor before choosing to invest money in the stock market. No offer or solicitation is being made to the viewing audience. I will never contact anyone outside of YouTube asking for anything. If you receive something appearing to be me, please disregard it. Viewership of this channel’s content constitutes agreement with this disclaimer. I will retain the right to remove comments or other interactions if they are inappropriate or offensive or I otherwise deem necessary. All videos on this channel are property of Fundamentals First Productions L.L.C. and may not be duplicated or disseminated without expressed written consent.

TRANSCRIPT:

What were the 2017 sales of Takeda Pharmaceutical?
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Watch this video to learn about Takeda Pharmaceutical.

TRANSCRIPT:

What are the total assets of Takeda Pharmaceutical?
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Watch this video to learn about Takeda Pharmaceutical.

TRANSCRIPT:

Where is Takeda Pharmaceutical headquartered?
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Watch this video to learn about Takeda Pharmaceutical.

TRANSCRIPT:

CEO Talk in English/en anglais with/avec Stefan Koenig, General Manager at Takeda Pharmaceutical
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

CEO Talk in English with Stefan Koenig, General Manager at Takeda Pharmaceutical (Switzerland) CEO Talk en anglais avec Stefan Koenig, General Manager at Takeda Pharmaceutical (Suisse) #ceotalks #leadership #ceo #generalmanager #takeda #stefankoenig

TRANSCRIPT:

How big of a company is Takeda Pharmaceutical?
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Watch this video to learn about Takeda Pharmaceutical.

TRANSCRIPT:

TAK Price and Volume Analysis by 650 Day Look Back TAK Stock Analysis for Takeda Pharmaceutical Stoc
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

What Were Price & Volume? How Did The Day Rank? Which Quartile Did The Day's Price & Volume Land? How Were Monthly Price & Volume Averages? What Were Monthly %Chg Avg. in Price & Volume? Has Ticker Reached Golden or Death Crosses? Entity Profile Important Disclaimer My Capitalistic Brothers and Sisters. Like and Subscribe! This Video was auto-generated by a Bot off drafted observational data models that remain in-progress. See Important Disclosure. Let us know which Ticker the Bot should cover next - write a comment! Thank you for watching. Check out our other Videos. IMPORTANT DISCLAIMER: This Video and its Content ("Video") is for entertainment purposes only. Absolutely no qualified, accredited, or professional investment and financial advice, information, data, research, product, service or otherwise, are presented, marketed, or offered in this Video. Additionally, no warranty, guarantee, assurance, or factual assertions are offered or stated in this Video. Never use this Video to influence or determine investment or financial decisions. Please consult a qualified licensed professional for your investment and financial needs; do so away from TickerDD and Youtube. Remember that investments are risky, whereby capital losses can occur in full or in excess. TickerDD, an in-progress Framework of Nerdy Data Science & Robotics Stuff, auto-generated this Video strictly for entertainment purposes, as part of an in-progress exercise by a Group of Novices who wants to discover and learn about specific facets of the Market, through trial and error. This Group of Novices are not licensed, accredited, or qualified financial or investment professionals. This Video is only material for entertainment purposes only. This Video, like all Videos uploaded by TickerDD, is only for this Group of Novices' private usage even if Videos are uploaded publicly as the Group leverages Youtube's free disk space. Importantly, TickerDD is not about stocks but is specifically about the discovery, through trial and error, of technologies and data that govern opinionated observational data models as this Group of Novices builds them quickly and iteratively as part of learning). This Video wholly contains opinions and commentaries, even if they were auto-generated. Remember that Bots, Data Models, Data, and Methods may include hidden assumptions, undefined and unrefined variables, as well as errors and unfit approaches - all of which can and will exist in this very Video. Therefore, this Video, by its auto-generation date and time, listed on this slide, and by its sourced and abstracted third-party public data are offered as-is. Your access, view, and share of this Video constitute your acknowledged agreement that this Video is for your entertainment purposes only and that you will not take actions or make decisions off it. As such, you grant full release of claims, directly or indirectly, from your access, view, and share of this Video, against TickerDD and its affiliates. The people and entities, affiliated to the Ticker that is covered in this Video, are not affiliated with this Video and do not endorse this Video.

TRANSCRIPT: